A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Clinical trial NCT02247479 · TERMINATED
Trial details
- NCT number
- NCT02247479
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-18
- Primary completion
- 2018-01-29
- Enrollment
- 906
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.